ST:5 Flashcards
Which of the following personnel monitors would be appropriate for use when monitors are changed at 3 mo intervals?
(a)TLD or OSL
(b) TLD
(c) OSL
(d) film badge
(e) pocket dosimetry
(a) Either a TLD or an OSL can be used because the accuracy of the reading is not affected by time. The film in a film badge may begin to fog within this period of time. which may result in inaccurate exposure readings.
Patient preparation for infection imaging using tagged white blood cells includes:
(a)fasting for at least 4 hr with a blood glucose level below 120 mg/dL
(b) lab work and information concerning recent blood transfusions
(c) discontinuation of certain medications
(d) smoking cessation for at least 24 hr
(e) fasting for at least 4 hr with a blood glucose level below 200 mg/dL
(b) No special preparation is needed for a white blood cell infection imaging other than a possible interference if the patient has had a recent blood transfusion.
The percentage left ventricular ejection fraction calculated from the net counts per minute shown here: End diastole: 2875 End systole: 2162 is approximately: (a)25%
(b) 13%
(c) 33%
(d) 100%
(e) 75%
(a) The counts per minute are obtained from the regions of interest drawn around the end-diastolic and end-systolic images. The counts in each region are then corrected for background. The formula for calculating the left ventricular ejection fraction is:
LVEF = (net end-diastolic counts - net end-systolic counts) x 100 / net end-diastolic counts
= (2875 cpm - 2162 cpm) x 100 / 2875 cpm = 25%
On the basis of these data shown: Total counts - No. pixels Cardiac ROI - 28,503 - 417 Background ROI - 1,859 - 88 what are the net counts in the cardiac region of interest? (a)28,065
(b) 19,694
(c) 26,644
(d) 15,463
(e) 14,652
(b) Net counts are determined using a background (bkg) region of interest (ROI) drawn near the area of interest. The average counts per pixel in the bkg ROI are subtracted from the cardiac ROI, adjusted for the size of the region.
net cardiac ROI counts = cardiac ROI counts - ((bkg ROI counts / bkg ROI pixels) x cardiac ROI pixels)
28,503 cts - (1859 cts / 88 pixels) x 417 pixels
28,503 cts - (21 cts/pixel x 417 pixels)
28,503 cts - 8809 cts = 19,694 cts
According to the NRC, areas where therapeutic radiopharmaceuticals are prepared or administered must be surveyed:
(a)weekly
(b) monthly
(c) quarterly
(d) after each therapeutic dosage is prepared or administered
(e) at the end of each day a therapeutic dosage is prepared or administered
(e) NRC regulations require a survey of areas where radiopharmaceuticals that require a written directive are prepared for administered. This would include therapeutic radiopharmaceuticals and dosages of 131I greater than 30 uCi. the survey is to be performed at the end of the day. As of October 2002, the NRC no longer requires daily surveys and weekly wipe tests. Instead it allows facilities to establish a survey and wipe test schedule. the schedule must be reasonable, based on the need to determine radiation levels, concentrations or quantities of radioactive materials, and potential radiological hazards.
According to NRC regulations, which of the following signs should be posted in unrestricted areas?
(a)”Caution: Radioactive Materials”
(b) “Authorized Personnel Only”
(c) No posting is required.
(d) “Caution: Radiation Area”
(e) “Caution: High Radiation Area”
(c) According to the NRC, an unrestricted area is one in which access is not limited by or under control of a license. Unrestricted areas are not posted.
If 740 kBq of a radiopharmaceutical is to be administered for each kilogram of body weight, approximately how much activity (in megabecquerels) should be administered to a patient who weighs 172 pounds?
(a)9.5 MBq
(b) 652 MBq
(c) 78 MBq
(d) 280 MBq
(e) 58 MBq
(e) First convert the patient’s body weight into kilograms:
172 lbs x kg/2.2lbs = 78kg
Next, calculate the total activity to be administered to the patient based on body weight:
78 kg x 740 kBq/kg = 57,720 kBq
Then, convert kBq into MBq.
57,720 kBq x MBq/1000 kBq = 58 MBq
Which of the following is a primary source of radiation exposure to the technologist who performs PET imaging?
(a)Bremsstrahlung radiation from the patient
(b) positrons escaping from the patient
(c) y rays from the long-lived source used for transmission scanning
(d) electromagnetic radiation from the PET camera
(e) Compton scatter from the patient
(e) The primary sources of radiation exposure to the technologist who performs PET imaging are from the radiopharmaceutical dosages before and during administration and from the Compton scatter escaping the patient’s body. Because they are particles, positrons will be absorbed by body tissue and will not be emitted from the body.
Pentagastrin is commonly used in which of the following scans:
(a)gastric emptying
(b) deep vein thrombosis
(c) Meckel’s diverticulum
(d) LeVeen shunt patency
(e) myocardial perfusion imaging
(c) Pentagastrin stimulates ectopic gastric mucosal uptake of pertechnetate by 30%-60& while decreasing emptying time into small bowel and decreasing background.
Which of the following statements about the modified in vivo method for labeling red blood cells with [99mTc]pertechnetate is TRUE?
(a)Only a sample of the patient’s blood is incubated with the reconstituted stannous pyrophosphate.
(b) Red cell labeling takes place only within the patient’s circulatory system.
(c) A sample of the patient’s “pretinned” blood is incubated with [99mTc]pertechnetate outside of the patient.
(d) Excess [99mTc]pertechnetate is removed from the blood sample before the sample is re-injected into the patient.
(e) A larger amount of stannous pyrophosphate is used.
(c) The modified in vivo method for labeling red blood cells involves first administering “cold” stannous pyrophosphate to the patient. Then, a small sample (1-5 mL) of the patient’s blood is incubated with [99mTc]pertechnetate outside the patient. The in vitro method involves collecting a small blood sample that is first incubated with stannous ion, then [99mTc]pertechnetate outside the patient. The plasma containing unbound [99mTc]pertechnetate is removed and the red cells washed before reinjecting them. In the in vivo method, all labeling steps occur within the patient.
If a unit dosage of [99mTc]pertechnetate is calibrated to contain 25 mCi in 0.8 mL at 1400, what volume should be removed from the syringe to retain 15 mCi in the syringe at 1200?
(a)0.20 mL
(b) 0.32 mL
(c) 0.52 mL
(d) 0.48 mL
(e) 0.42 mL
(e) First, determine the total activity in the syringe at 1200 by backdecay-correcting the activity using the 2-hr decay factor (1200-1400 = 2 hr) for 99mTc:
25 mCi / 0.794 = 31.5 mCi
Then, determine the concentration at 1200:
concentration = total activity / total volume = 31.5 mCi / 0.8 mL = 39.4 mCi/mL
Determine the volume that will contain 15 mCi at 1200:
volume = activity required / concentration = 15 mCi / 39.4 mCi/mL = 0.38 mL
Determine the volume that will have to be removed from the syringe:
total - volume required = volume to be removed
0.8 mL - 0.38 mL = 0.42 mL
If a patient receives 20 mCi of [131I]sodium iodide instead of the prescribed dosage of 15 mCi for therapy of hyperthyroidism, which of the following individuals/agencies must be notified?
(a)NRC
(b) NRC and referring physician
(c) referring physician
(d) NRC and FDA
(e) FDA
(b) When a medical event (misadministration) occurs, the NRC requires the license to notify the NRC, the referring physician, and the involved individual, unless the referring physician determines, on the basis of medical judgment, that such notification would be harmful to the patient.
One advantage of the in vivo method of 99mTc red cell tagging is that:
(a)No manipulation of blood samples outside the body is required.
(b) No incubation times are required at any step in the process.
(c) All circulating red cells are labeled with tracer.
(d) Smaller amounts of stannous chloride are required.
(e) White blood cells do not interfere in the process.
(a) The major advantage of in vivo red cell labeling is that tagging takes place in the circulatory system. The patient first receives reconstituted “cold” pyrophosphate containing stannous ion that permits [99mTc]pertechnetate to permeate red cell membranes. After a short incubation period to allow the stannous ion to come into contact with the red cells, the patient is injected with [99mTc]pertechnetate. After another short incubation period when the tracer becomes incorporated in the red cells, imaging begins.
In a hospital setting, CPR CANNOT legally be administered to a patient in cardiac arrest when the:
(a)patient has an infectious disease
(b) patient’s spouse or significant other indicates their wishes
(c) patient is hallucinating
(d) patient’s chart indicates a terminal illness
(e) patient’s chart indicates DNR
(e) CPR should always be administered to a patient in cardiac arrest unless the patient, patient’s family, or patient’s physician has specifically requested that it not be done. In these cases, DNR (Do Not Resuscitate) or “allow natural death” should be clearly indicated on the patient’s chart.
In what way does the modified in vivo method of labeling red blood cells with [99mTc]pertechnetate differ from the in vivo method?
(a)The modified method requires a smaller amount of stannous pyrophosphate.
(b) The modified method “pretins” only a small volume of the patient’s blood.
(c) The modified method uses a smaller activity of [99mTc]pertechnetate.
(d) The modified method mixes [99mTc]pertechnetate with only a small volume of the patient’s blood.
(e) The modified method requires a larger amount of stannous pyrophosphate.
(d) In both the in vivo and modified in vivo methods of labeling red blood cells with [99mTc]pertechnetate, reconstituted stannous pyrophosphate is injected intravenously into the patient. Hence, the same amount of stannous pyrophosphate is administered, and the entire volume of the patient’s blood is “pretinned” in either method. Both methods use 20 to 30 millicuries of [99mTc]pertechnetate. The main difference in the modified in vivo method is that only a small volume (~3 mL) of the patient’s pretinned blood is mixed with [99mTc]pertechnetate in a syringe. In the in vivo method, [99mTc]pertechnetate is injected intravenously 15-30 min after stannous pyrophosphate.
For a patient undergoing bone imaging, which of the following information from the medical history is relevant to the interpretation of the bone image?
(a)splenectomy 5 years ago
(b) abdominal surgery 10 days ago
(c) radiation therapy to the breast 6 months ago
(d) gallbladder surgery a year ago
(e) results of previous bone imaging procedures
(e) Results of previous bone imaging procedures performed with nuclear medicine or another imaging modality may provide additional information not demonstrated on the current image or indications that the condition has improved or worsened. Healing soft tissue, such as that resulting from recent abdominal surgery, will concentrate bone tracer in an unexpected area. External beam radiation therapy can cause photopenic areas-areas of decreased tracer activity- on the bone image in the area where the therapy was delivered. All of this information will help the physician explain the findings on a bone image.
[111In]Pentetreotide normally localizes in all of the following sites EXCEPT:
(a)pituitary gland
(b) salivary glands
(c) spleen
(d) thyroid gland
(e) liver
(b) [111In]pentetreotide normally localizes in the pituitary gland, thyroid gland, liver, spleen, bladder, and bowel.
SPECT brain imaging may begin how soon after the administration of [99mTc]exametazime?
(a)immediately
(b) 1-2 hr
(c) 15-20 min
(d) 24 hr
(e) 48 hr
(b) For the best image quality, brain imaging with [99mTc]exametazime should begin no sooner than 90 min after the administration of the tracer.
An eluate of [99mTc]pertechnetate is assayed for 99Mo contamination with the following results:
99Mo: 45 uCi
99mTc: 275 mCi
On the basis of this assay, the technologist should:
(a)Wait for the 99Mo to decay to an acceptable level.
(b) Use the eluate only for studies requiring other 99mTc-labeled agents.
(c) Discard the eluate.
(d) Use the eluate for only the next 12 hr.
(e) Wait for the 99mTc to decay to an acceptable level.
(c) The 99Mo concentration in this eluate is equal to:
45 uCi / 275 mCi = 0.16 uCi 99Mo/mCi 99mTc
This 99Mo concentration exceeds the maximum allowable limit of 0.15 uCi 99Mo/mCi 99mTc set by the NRC. Therefore, the technologist must not administer the eluate to patients either as [99mTc]pertechnetate or as some other 99mTc-labeled compound. Also, remember that radionuclide purity changes with time. Because 99Mo (T1/2 = 66 hr) decays more slowly than 99mTc (T1/2 = 6 hr), the ratio of 99Mo to 99mTc will increase with time, exceeding the maximum allowable limit to a greater extent.
In performing a thyroid uptake, a technologist collects the thyroid counts 5 cm from the surface of the patient’s neck and the standard counts 20 cm from the surface of the neck phantom. What is the effect on the thyroid uptake value calculated from this data?
(a)The uptake value will be falsely increased.
(b) The uptake value will be falsely decreased.
(c) The uptake value will be accurate.
(d) The results are unpredictable.
(e) There is no effect.
(a) Recall that, as a point source is moved closer to the face of a flat-field collimator, more counts are collected. If the standard represents the total amount of activity administered to the patient, the counts collected from the patient’s neck represent a portion of the total amount of activity that concentrated in the thyroid gland. It is important, therefore, based on the response of the detector at a given distance, to count both the standard and the patient at the same distance. For example, suppose the standard and the patient were both counted at 20 cm, and 20,000 net cpm and 5,000 net cpm were obtained, respectively. The patient’s uptake is:
neck counts x 100 / standard counts = 5000 cpm x 100 / 20,000 cpm = 25%
If the patient were counted at 5 cm instead of 20 cm, more counts would be collected (i.e., 10,000 cpm). Then, the patient’s uptake is falsely increased:
neck counts x 100 / standard counts = 10000 cpm x 100 / 20,000 cpm = 50%
Which of the following techniques is used to help eliminate the “star” effect created during tomographic reconstruction?
(a)filtered backprojection
(b) center of rotation offset correction
(c) oversampling
(d) uniformity correction
(e) iterative reconstruction
(a) Tomographic images may be reconstructed from the planar projections using a technique called backprojection. This creates a star pattern as the ray sums are projected back along a line in the reconstruction matrix. the use of a ramp filter during the process helps eliminate much of the “star” artifact.
Boiling a [99mTc]sulfur colloid preparation for too long will result in colloidal particles that are:
(a)too small
(b) clumpy
(c) optimal size
(d) chemically unstable
(e) too large
(e) The diameter of the colloid particle is increased as a function of heating time. Thus, the longer the 99mTc preparation is heated, the larger the sulfur colloid particles become. Extended heating times, beyond what is recommended in the package insert, result in particles large enough to become trapped in the lung vasculature.
If a 67Ga static image is acquired into a 128 x 128 byte mode matrix using the photopeaks at 93, 185, and 300 keV, how much computer memory is required to store the image?
(a)256 kB
(b) 64 kB
(c) 32 kB
(d) 128 kB
(e) 16 kB
(e) Counts from the three photopeaks are collected in one acquisition matrix to form a single 67Ga image. Therefore, one set of storage locations in computer memory is needed. One 128 x 128 byte-mode matrix contains 16,384 bytes. A kilobyte (kB) contains 1,024 bytes. To convert bytes to kilobytes:
16,384 bytes x 1 kB/1024 bytes = 16 kB
Early (6 hr after injection) 67Ga imaging should be performed if which of the following conditions is suspected?
(a)sarcoma
(b) osteomyelitis
(c) lymphoma
(d) bronchogenic carcinoma
(e) chrondrosarcoma
(b) 67Ga imaging can be performed form 6 hr to 3 days or longer after tracer administration. When the examination is being performed for evaluation of an inflammatory process, early imaging (6 hr after injection) is indicated.